Clinical trials
Observational Liver Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Completed | 2 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Academisch Ziekenhuis Maastricht | 1 |
| Bayer | 1 |
| Erasmus Medical Center | 1 |
| Ethicon, Inc. | 1 |
| Leiden University Medical Center | 1 |
| Maastricht University Medical Center | 1 |
| Mark C Burgmans, MD PhD | 1 |
| Prof. Valérie Mc Lin | 1 |
| UMC Utrecht | 1 |
| dr. M.P. van den Tol MD PhD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Neoplasms | 10 |
| Carcinoma, Hepatocellular | 3 |
| Lung Neoplasms | 2 |
| Neoplasms | 2 |
| Bone Neoplasms | 1 |
| Brain Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Renal Cell | 1 |
| Cholangiocarcinoma | 1 |
| Congenital Portosystemic Shunt | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.